We are live on
!
Find out more
Iconiq Capital Portfolio holdings
AUM
$3.47B
Turnover
22.47%
1-Year Est. Return
23.76%
This Fund
S&P 500
This Quarter
Est. Return
+1.62%
1 Year Est. Return
-23.76%
3 Year Est. Return
+0.21%
5 Year Est. Return
-19.72%
10 Year Est. Return
+465.2%
AUM
$970M
AUM Growth
-$33.4M
(-3.3%)
Cap. Flow
-$43.2M
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
87.18%
Holding
64
New
5
Increased
13
Reduced
10
Closed
3
Avg Time Held
2.1
years
Top 10 Avg Time Held
2.3
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Niagen Bioscience
NAGE
|
+$9.22M |
| 2 |
Apple
AAPL
|
+$4.12M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$3.06M |
| 4 |
Apollo Commercial Real Estate
ARI
|
+$1.51M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$1.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BlackLine
BL
|
+$50.7M |
| 2 |
iShares Select Dividend ETF
DVY
|
+$7.52M |
| 3 |
Alibaba
BABA
|
+$2.83M |
| 4 |
SPDR Gold Trust
GLD
|
+$2.47M |
| 5 |
KKR & Co
KKR
|
+$1.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.05% |
| 2 | Technology | 32.08% |
| 3 | Consumer Discretionary | 14.84% |
| 4 | Communication Services | 7.08% |
| 5 | Consumer Staples | 1.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Alphabet (Google) Class C
GOOG
$4.11T
| $315K | 0.03% |
6,020
+120
| +2% | +$6.11K |
2017 Q3
1 quarter
|
|
|
AKAO
52
DELISTED
Achaogen Inc
AKAO
| $307K | 0.03% |
28,629
| – | – |
2015 Q3
9 quarters
|
|
53
Vanguard FTSE All-World ex-US ETF
VEU
$66.9B
| $306K | 0.03% |
5,591
| – | – |
2017 Q3
1 quarter
|
|
54
Chevron
CVX
$441B
| $304K | 0.03% |
2,432
+32
| +1% | +$3.79K |
2015 Q4
8 quarters
|
|
55
iShares International Select Dividend ETF
IDV
$8.31B
| $256K | 0.03% |
7,576
| – | – |
2015 Q2
10 quarters
|
|
56
Enterprise Products Partners
EPD
$78.8B
| $230K | 0.02% |
8,670
-1,324
| -13% | -$33.5K |
2014 Q3
13 quarters
|
|
57
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $214K | 0.02% |
4,090
| – | – |
2015 Q3
9 quarters
|
|
|
CALA
58
DELISTED
Calithera Biosciences, Inc
CALA
| $194K | 0.02% |
1,161
| – | – |
2017 Q1
3 quarters
|
|
|
OCIP
59
DELISTED
OCI Partners LP
OCIP
| $144K | 0.01% |
17,835
| – | – |
2014 Q2
14 quarters
|
|
60
VivoSim Labs
VIVS
$2.1M
| $18K | ﹤0.01% |
55
| – | – |
2016 Q4
4 quarters
|
|
61
DELISTED
Genesis Healthcare, Inc.
GEN
| $9K | ﹤0.01% |
11,500
| – | – |
2017 Q3
1 quarter
|
|
|
62
KKR & Co
KKR
$77.7B
| – | – |
-63,290
| Closed | -$1.29M | – |
|
63
Par Pacific Holdings
PARR
$4.19B
| – | – |
-23,842
| Closed | -$496K | – |
|
64
DELISTED
Pioneer Natural Resource Co.
PXD
| – | – |
-1,369
| Closed | -$202K | – |
|
Similar funds
TC
ATC
TCG
JIC
NBS
MC
Iconiq Capital's Q4 2017 Portfolio in Review
As of Q4 2017, Iconiq Capital held 64 positions worth $970M, down 3.3% from $1B the previous quarter. Its ten largest holdings account for 87% of the portfolio.
Iconiq Capital withdrew a net $43.2M in Q4 2017, closing 3 positions and reducing 10 holdings. Its most notable exit was KKR & Co, an estimated $1.29M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 41% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Iconiq Capital opened a new position in Niagen Bioscience worth $10M.
- Iconiq Capital's largest Q4 2017 buy was Niagen Bioscience: 1,707,317 shares worth $10M.
- Iconiq Capital added most to Apple in Q4 2017, an estimated $4.12M increase.
- Iconiq Capital's biggest Q4 2017 reduction was BlackLine, cutting an estimated $50.7M.
- Iconiq Capital fully exited KKR & Co in Q4 2017, selling an estimated $1.29M.
- Iconiq Capital's ten largest holdings make up 87% of its $970M portfolio in Q4 2017.
- Iconiq Capital opened 5 new positions and closed 3 in Q4 2017.
- Iconiq Capital's portfolio value fell 3.3% quarter-over-quarter to $970M.
Based on Iconiq Capital's 13F filing for Q4 2017, filed 14 Feb 2018.